12/2
03:46 pm
tenx
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
01:57 pm
tenx
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
08:01 am
tenx
Tenax Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Tenax Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/25
07:00 am
tenx
Tenax Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Tenax Therapeutics to Participate in Upcoming Investor Conferences
11/13
09:36 pm
tenx
Tenax Therapeutics, Inc. (TENX) Discusses Scientific Rationale and Development Strategy for TNX-103 in PH-HFpEF Transcript [Seeking Alpha]
Low
Report
Tenax Therapeutics, Inc. (TENX) Discusses Scientific Rationale and Development Strategy for TNX-103 in PH-HFpEF Transcript [Seeking Alpha]
11/13
12:50 am
tenx
Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72 [Seeking Alpha]
Medium
Report
Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72 [Seeking Alpha]
11/12
04:53 pm
tenx
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
04:05 pm
tenx
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/12
01:30 pm
tenx
Tenax Therapeutics (NASDAQ:TENX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
07:00 am
tenx
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF
Low
Report
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF
11/3
07:00 am
tenx
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Neutral
Report
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
10/25
01:32 am
tenx
Tenax Therapeutics (NASDAQ:TENX) was upgraded by analysts at
Wall Street
Low
Report
Tenax Therapeutics (NASDAQ:TENX) was upgraded by analysts at
Wall Street
10/14
12:17 pm
tenx
Tenax Therapeutics (NASDAQ:TENX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/16
07:00 am
tenx
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Medium
Report
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
9/8
08:05 am
tenx
Tenax Therapeutics (NASDAQ:TENX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $20.00 price target on the stock.
Low
Report
Tenax Therapeutics (NASDAQ:TENX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $20.00 price target on the stock.